Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium

Angela Prvulovic

May 4, 2022

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium hosted by the Gavin Herbert Eye Institute at the University of California, Irvine School of Medicine. Dr. Gandhi discusses novel tools for approaching translational vision and translational neuroscience.

Access Dr. Gandhi's presentation recording titled, "Tools for Brain-wide Quantification of Neural and Immune Cell Activity at Single-Cell Resolution" below.

Ask your question

Send us your questions and we will get back to you as soon as possible
info@translucencebio.com

Thank you! Your submission has been received!

Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

January 31, 2023

Updates

Translucence Biosystems Participates in Keystone Meeting on Drug Delivery to the Brain

Our team has been working with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. Our CEO, Damian Wheeler, Ph.D. presented our findings in our poster titled the "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."

Translucence Biosystems

Learn More

November 13, 2022

Research

Translucence Biosystems Presents at SfN 2022

The Translucence team, including Nate Guanzon, Chase Redd, and CEO Damian Wheeler presented our BRAIN Initiative-funded work on whole-brain quantification neuronal activity with Npas4 and cFos at SfN 2022.

Translucence Biosystems

Learn More

September 29, 2021

Achievements

Translucence Biosystems is a 2021 High Tech Awards finalist

Translucence Biosystems is a finalist in the Outstanding Emerging Technology Company category at Octane OC's 2021 High Tech Awards (HTA). Special thanks to University Lab Partners for making our work possible!

Damian Wheeler

Learn More